EyePoint Pharmaceuticals SG&A Expense (TTM) Analysis

EyePoint Pharmaceuticals Inc (EYPT)

8.43 -0.19 (-2.20%) USD | NASDAQ | Jul 05, 15:37

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2008. Upgrade now.

Date	Value
March 31, 2024	50.92M
December 31, 2023	51.79M
September 30, 2023	54.77M
June 30, 2023	58.96M
March 31, 2023	60.06M
December 31, 2022	60.32M
September 30, 2022	62.94M
June 30, 2022	61.14M
March 31, 2022	57.55M
December 31, 2021	53.08M
September 30, 2021	47.64M
June 30, 2021	45.27M
March 31, 2021	44.31M
December 31, 2020	46.02M
September 30, 2020	45.98M
June 30, 2020	47.06M
March 31, 2020	48.28M
December 31, 2019	47.71M
September 30, 2019	43.97M
June 30, 2019	37.56M
March 31, 2019	27.74M
September 30, 2018	18.29M
June 30, 2018	13.06M
March 31, 2018	9.949M
December 31, 2017	10.09M

Date	Value
September 30, 2017	10.52M
June 30, 2017	11.24M
March 31, 2017	11.27M
December 31, 2016	11.19M
September 30, 2016	10.33M
June 30, 2016	9.013M
March 31, 2016	8.768M
December 31, 2015	8.463M
September 30, 2015	8.29M
June 30, 2015	8.056M
March 31, 2015	7.645M
December 31, 2014	7.55M
September 30, 2014	7.391M
June 30, 2014	7.468M
March 31, 2014	7.621M
December 31, 2013	7.413M
September 30, 2013	7.36M
June 30, 2013	7.169M
March 31, 2013	6.615M
December 31, 2012	6.634M
September 30, 2012	6.427M
June 30, 2012	6.868M
March 31, 2012	7.441M
December 31, 2011	7.446M
September 30, 2011	7.996M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

43.97M

Minimum

Sep 2019

62.94M

Maximum

Sep 2022

51.99M

Average

50.92M

Median

Mar 2024

SG&A Expense (TTM) Benchmarks